AGL Stock Analysis: Buy, Sell, or Hold?
AGL - agilon health, inc.
$0.32
-0.07 (-18.88%)
▼
5d:
-26.94%
30d:
-45.46%
90d:
-55.72%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 05, 2026
Get Alerted When AGL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AGL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AGL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AGL is currently trading at $0.32, which is considered oversold relative to its 30-day fair value range of $0.42 to $0.62.
Technical Outlook: Technically, AGL is in a strong downtrend. The price is currently testing key support at $0.34. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 18.9% recently.
Market Sentiment: AGL has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $0.94 (+138.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AGL is in a strong downtrend. The price is currently testing key support at $0.34. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 18.9% recently.
Market Sentiment: AGL has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $0.94 (+138.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.42 -
$0.62
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-18.9%)
- BULLISH: Trading 138.3% below Wall St target ($0.94)
- CAUTION: 5-day price weakness (-26.9%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.42 -
$0.62
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.34
Resistance Level
$0.62
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.20
Wall Street Target
$0.94
(+138.3%)
Revenue Growth (YoY)
3.1%
Earnings Growth (YoY)
1195.1%
Profit Margin
-6.6%
Share & Embed Analysis
Last updated: March 30, 2026 4:27 PM ET
Data refreshes hourly during market hours. Next update: 5:27 PM
Data refreshes hourly during market hours. Next update: 5:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AGL showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
John William Wulf
BUY
81000 shares
2025-11-12
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$261 | 62 BUY |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$543 | 64 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 48 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$140 | 54 HOLD |
